Prognostic value of serial brain natriuretic peptide measurements in patients with acute myocardial infarction

Cardiology (Switzerland)

Volumn 131, Issue 2, 2015, Pages 116-121

  Pesaro, Antonio E P ^a   Katz, Marcelo ^a   Caixeta, Adriano ^a   Makdisse, Márcia R ^a   Correia, Alessandra G ^a   Pereira, Carolina ^a   Franken, Marcelo ^a   Fava, Anderson N ^a   Serrano, Carlos V ^a,b  

^a HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acute myocardial infarction; B type natriuretic peptide; Prognostic

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATININE; TROPONIN I; BIOLOGICAL MARKER;

ACUTE HEART INFARCTION; AGE; AGED; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CARDIAC PATIENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; FOLLOW UP; GENDER; HEART LEFT VENTRICLE EJECTION FRACTION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; BLOOD; HEART INFARCTION; HOSPITAL MORTALITY; LENGTH OF STAY; METABOLISM;

AGED; BIOMARKERS; FEMALE; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; MALE; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 84928128541     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000375398     Document Type: Article

References (20)

1. Hamm CW, Heeschen C, Goldmann B, Vahanian A, Adgey J, Miguel CM, Rutsch W, Berger J, Kootstra J, Simoons M: Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels: c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. N Engl J Med 1999; 340: 1623-1629.
2. Maisel AS, Krishnaswamy P, Nowak RM, Mc-Cord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA; Breathing Not Properly Multinational Study Investigators: Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161-167.
3. de Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH, Hall C, Cannon CP, Braunwald E: The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001; 345: 1014-1021.
4. Haaf P, Balmelli C, Reichlin T, Twerenbold R, Reiter M, Meissner J, Schaub N, Stelzig C, Freese M, Paniz P, Meune C, Drexler B, Freidank H, Winkler K, Hochholzer W, Mueller C: N-terminal pro B-type natriuretic peptide in the early evaluation of suspected acute myocardial infarction. Am J Med 2011; 124: 731-739.
5. Rezende PC, Katz M, Pesaro AEP, Kanamaru F, Makdisse MRP, Correa AG, Forlenza LMA, Franken M, Fava AN, Buzatto LL, Serrano CV Jr: The paradoxical association between brain natriuretic peptide and obesity in patients with acute myocardial infarction. Exp Clin Cardiol 2014; 6: 145-153.
6. Hill SA, Booth RA, Santaguida PL, Don-Wauchope A, Brown JA, Oremus M, Ali U, Bustamam A, Sohel N, McKelvie R, Balion C, Raina P: Use of BNP and NT-proBNP for the diagnosis of heart failure in the emergency department: a systematic review of the evidence. Heart Fail Rev 2014; 19: 421-438.
7. Faggiano P, Valle R, Aspromonte N, D'Aloia A, Di Tano G, Barro S, Giovinazzo P, Milani L, Lorusso R, Dei Cas L: How do often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure Role of serial measurements to improve short-term prognostic stratification. Int J Cardiol 2010; 140: 88-94.
8. Januzzi JL, Troughton R: Syndrome management: are serial BNP measurements useful in heart failure management Serial natriuretic peptide measurements are useful in heart failure management. Circulation 2013; 127: 500-507.
9. Pfisterer M, Buser P, Rickli H, Gutmann M, Erne P, Rickenbacher P, Vuillomenet A, Jeker U, Dubach P, Beer H, Yoon SI, Suter T, Osterhues HH, Schieber MM, Hilti P, Schindler R, Brunner-La Rocca HP; TIME-CHF Investigators: BNP-guided versus symptom-guided heart failure therapy: the Trial of Intensified versus Standard Medical Therapy in Elderly Patients with Congestive Heart Failure (TIME-CHF) randomized trial. JAMA 2009; 301: 383-392.
10. Ang DS, Welsh P, Watt P, Nelson SM, Struthers A, Sattar N: Serial changes in adiponectin and BNP in ACS patients: paradoxical associations with each other and with prognosis. Clin Sci (Lond) 2009; 117: 41-48.
11. Fertin M, Hennache B, Hamon M, Ennezat PV, Biausque F, Elkohen M, Nugue O, Tricot O, Lamblin N, Pinet F, Bauters C: Usefulness of serial assessment of B-type natriuretic peptide, troponin I, and C-reactive protein to predict left ventricular remodeling after acute myocardial infarction (from the REVE-2 study). Am J Cardiol 2010; 106: 1410-1416.
12. Heeschen C, Hamm CW, Mitrovic V, Lantelme NH, White HD; Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators: N-terminal pro-Btype natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 2004; 110: 3206-3212.
13. Lindahl B, Lindback J, Jernberg T, Johnston N, Stridsberg M, Venge P, Wallentin L: Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and Fast Revascularisation during Instability in Coronary Artery Disease (FRISC)-II substudy. J Am Coll Cardiol 2005; 45: 533-541.
14. Makdisse M, Katz M, Correa Ada G, Forlenza LM, Perin MA, de Brito Junior FS, Nascimento TC, Gomes IM, Franken M, Knobel M, Pesaro AE, dos Santos OF, Cendoroglo Neto M, Lottenberg CL: Effect of implementing an acute myocardial infarction guideline on quality indicators. Einstein (Sao Paulo) 2013; 11: 357-363.
15. Alpert JS, Thygesen K, Antman E, Bassand JP: Myocardial infarction redefined-A consensus document of the Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959-969.
16. Palmer BR, Pilbrow AP, Yandle TG, et al: Angiotensin-converting enzyme gene polymorphism interacts with left ventricular ejection fraction and brain natriuretic peptide levels to predict mortality after myocardial infarction. J Am Coll Cardiol 2003; 41: 729-736.
17. James SK, Lindahl B, Siegbahn A, et al: N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease. Circulation 2003; 108: 275-281.
18. Omland T, Persson A, Ng L, et al: N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 2002; 106: 2913-2918.
19. Suzuki S, Yoshimura M, Nakayama M, Mizuno Y, Harada E, Ito T, Nakamura S, Abe K, Yamamuro M, Sakamoto T, Saito Y, Nakao K, Yasue H, Ogawa H: Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction: a long-term follow-up analysis. Circulation 2004; 110: 1387-1391.
20. Talwar S, Squire IB, Downie PF, Mccullough AM, Campton MC, Davies JE, Barnett DB, Ng LL: Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction. Eur Heart J 2000; 21: 1514-1521.